136
Views
24
CrossRef citations to date
0
Altmetric
Review

Chemoprevention of prostate cancer with nutrients and supplements

&
Pages 91-100 | Published online: 30 Sep 2022

References

  • ShimizuHRossRKBernsteinLYataniRHendersonBEMackTMCancers of the prostate and breast among Japanese and white immigrants in Los Angeles CountyBr J Cancer19916369639662069852
  • MarksLSKojimaMDemarzoAProstate cancer in native Japanese and Japanese-American men: effects of dietary differences on prostatic tissueUrology200464476577115491717
  • LeeJDemissieKLuSERhoadsGGCancer incidence among Korean-American immigrants in the United States and native Koreans in South KoreaCancer Control2007141788517242674
  • ChanJMStampferMJGiovannucciELWhat causes prostate cancer? A brief summary of the epidemiologySemin Cancer Biol1998842632739870033
  • SyedDNKhanNAfaqFMukhtarHChemoprevention of prostate cancer through dietary agents: progress and promiseCancer Epidemiol Biomarkers Prev200716112193220318006906
  • Duffield-LillicoAJDalkinBLReidMESelenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer TrialBJU Int200391760861212699469
  • The Alpha-Tocopherol BCCPSGThe effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study GroupN Engl J Med199433015102910358127329
  • HeinonenOPAlbanesDVirtamoJProstate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trialJ Natl Cancer Inst19989064404469521168
  • WattersJLGailMHWeinsteinSJVirtamoJAlbanesDAssociations between alpha-tocopherol, beta-carotene, and retinol and prostate cancer survivalCancer Res20096993833384119383902
  • LippmanSMKleinEAGoodmanPJEffect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)JAMA20093011395119066370
  • GazianoJMGlynnRJChristenWGVitamins E and C in the prevention of prostate and total cancer in men: the Physicians’ Health Study II randomized controlled trialJAMA20093011526219066368
  • ChanJMOhWKXieWPlasma selenium, manganese superoxide dismutase, and intermediate-or high-risk prostate cancerJ Clin Oncol200927223577358319528373
  • KristalARArnoldKBNeuhouserMLDiet, supplement use, and prostate cancer risk: results from the prostate cancer prevention trialAm J Epidemiol2010172556657720693267
  • PetersULittmanAJKristalARPattersonREPotterJDWhiteEVitamin E and selenium supplementation and risk of prostate cancer in the Vitamins and lifestyle (VITAL) study cohortCancer Causes Control2008191758717943452
  • MarshallJRSakrWWoodDDesign and progress of a trial of selenium to prevent prostate cancer among men with high-grade prostatic intraepithelial neoplasiaCancer Epidemiol Biomarkers Prev20061581479148416896036
  • MarshallJRTangenCMSakrWASouthwest Oncology Group (SWOG) trial S9917: randomized phase 3 trial of selenium supplementation to prevent prostate cancer among men with high grade prostatic intraepithelial neoplasia (HGPIN)American Urological Association Annual MeetingMay 29–June 3, 2010San Francisco, CA
  • AdlercreutzHPhyto-oestrogens and cancerLancet Oncol20023636437312107024
  • MessinaMNagataCWuAHEstimated Asian adult soy protein and isoflavone intakesNutr Cancer200655111216965235
  • SwamiSKrishnanAVPeehlDMFeldmanDGenistein potentiates the growth inhibitory effects of 1,25-dihydroxyvitamin D3 in DU145 human prostate cancer cells: role of the direct inhibition of CYP24 enzyme activityMol Cell Endocrinol20052411–2496115955619
  • SwamiSKrishnanAVMorenoJBhattacharyyaRBPeehlDMFeldmanDCalcitriol and genistein actions to inhibit the prostaglandin pathway: potential combination therapy to treat prostate cancerJ Nutr20071371 Suppl205S210S17182827
  • DavisJNKucukOSarkarFHExpression of prostate-specific antigen is transcriptionally regulated by genistein in prostate cancer cellsMol Carcinog20023429110112112315
  • LakshmanMXuLAnanthanarayananVDietary genistein inhibits metastasis of human prostate cancer in miceCancer Res20086862024203218339885
  • El TounyLHBanerjeePPIdentification of a biphasic role for genistein in the regulation of prostate cancer growth and metastasisCancer Res20096983695370319351854
  • NagataCInabaSKawakamiNKakizoeTShimizuHInverse association of soy product intake with serum androgen and estrogen concentrations in Japanese menNutr Cancer2000361141810798211
  • HolzbeierleinJMMcIntoshJThrasherJBThe role of soy phytoestrogens in prostate cancerCurr Opin Urol2005151172215586024
  • EvansBAGriffithsKMortonMSInhibition of 5 alpha-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoidsJ Endocrinol199514722953027490559
  • HedlundTEJohannesWUMillerGJSoy isoflavonoid equol modulates the growth of benign and malignant prostatic epithelial cells in vitroProstate2003541687812481257
  • HebertJRHurleyTGOlendzkiBCTeasJMaYHamplJSNutritional and socioeconomic factors in relation to prostate cancer mortality: a cross-national studyJ Natl Cancer Inst19989021163716479811313
  • LeeMMGomezSLChangJSWeyMWangRTHsingAWSoy and isoflavone consumption in relation to prostate cancer risk in ChinaCancer Epidemiol Biomarkers Prev200312766566812869409
  • OzasaKNakaoMWatanabeYSerum phytoestrogens and prostate cancer risk in a nested case-control study among Japanese menCancer Sci2004951657114720329
  • NagataYSonodaTMoriMDietary isoflavones may protect against prostate cancer in Japanese menJ Nutr200713781974197917634273
  • KurahashiNIwasakiMSasazukiSOtaniTInoueMTsuganeSSoy product and isoflavone consumption in relation to prostate cancer in Japanese menCancer Epidemiol Biomarkers Prev200716353854517337648
  • GanryOPhytoestrogens and prostate cancer riskPrev Med20054111615916986
  • HorvathLGHenshallSMLeeCSFrequent loss of estrogen receptor-beta expression in prostate cancerCancer Res200161145331533511454669
  • LeavILauKMAdamsJYComparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinomaAm J Pathol20011591799211438457
  • TravisRCSpencerEAAllenNEPlasma phyto-oestrogens and prostate cancer in the European Prospective Investigation into Cancer and NutritionBr J Cancer2009100111817182319436304
  • KurahashiNIwasakiMInoueMSasazukiSTsuganeSPlasma isoflavones and subsequent risk of prostate cancer in a nested case-control study: the Japan Public Health CenterJ Clin Oncol200826365923592919018085
  • JoniauSGoemanLRoskamsTLerutEOyenRVan PoppelHEffect of nutritional supplement challenge in patients with isolated high-grade prostatic intraepithelial neoplasiaUrology20076961102110617572195
  • Hamilton-ReevesJMRebelloSAThomasWKurzerMSSlatonJWEffects of soy protein isolate consumption on prostate cancer biomarkers in men with HGPIN, ASAP, and low-grade prostate cancerNutr Cancer200860171318444130
  • JacobsenBKKnutsenSFFraserGEDoes high soy milk intake reduce prostate cancer incidence? The Adventist Health Study (United States)Cancer Causes Control19989655355710189040
  • HealdCLRitchieMRBolton-SmithCMortonMSAlexanderFEPhyto-oestrogens and risk of prostate cancer in Scottish menBr J Nutr200798238839617403269
  • HedlundTEMaroniPDFerucciPGLong-term dietary habits affect soy isoflavone metabolism and accumulation in prostatic fluid in caucasian menJ Nutr200513561400140615930444
  • RannikkoAPetasARannikkoSAdlercreutzHPlasma and prostate phytoestrogen concentrations in prostate cancer patients after oral phytoestogen supplementationProstate2006661828716114063
  • GardnerCDOelrichBLiuJPFeldmanDFrankeAABrooksJDProstatic soy isoflavone concentrations exceed serum levels after dietary supplementationProstate200969771972619180569
  • NielsenILWilliamsonGReview of the factors affecting bioavailability of soy isoflavones in humansNutr Cancer200757111017516857
  • HussainMBanerjeeMSarkarFHSoy isoflavones in the treatment of prostate cancerNutr Cancer200347211111715087261
  • SpentzosDMantzorosCReganMMMinimal effect of a low-fat/high soy diet for asymptomatic, hormonally naive prostate cancer patientsClin Cancer Res2003993282328712960113
  • VaishampayanUHussainMBanerjeeMLycopene and soy isoflavones in the treatment of prostate cancerNutr Cancer20075911717927495
  • PeraboFGVon LowECEllingerJvon RuckerAMullerSCBastianPJSoy isoflavone genistein in prevention and treatment of prostate cancerProstate Cancer Prostatic Dis200811161217923857
  • YanLSpitznagelELSoy consumption and prostate cancer risk in men: a revisit of a meta-analysisAm J Clin Nutr20098941155116319211820
  • De SouzaPLRussellPJKearsleyJHHowesLGClinical pharmacology of isoflavones and its relevance for potential prevention of prostate cancerNutr Rev201068954255520796219
  • LevyJBosinEFeldmanBLycopene is a more potent inhibitor of human cancer cell proliferation than either alpha-carotene or beta-caroteneNutr Cancer19952432572668610045
  • GiovannucciERimmEBLiuYStampferMJWillettWCA prospective study of tomato products, lycopene, and prostate cancer riskJ Natl Cancer Inst200294539139811880478
  • WuKErdmanJWJrSchwartzSJPlasma and dietary carotenoids, and the risk of prostate cancer: a nested case-control studyCancer Epidemiol Biomarkers Prev200413226026914973107
  • KucukOSarkarFHSakrWPhase II randomized clinical trial of lycopene supplementation before radical prostatectomyCancer Epidemiol Biomarkers Prev200110886186811489752
  • ChenLStacewicz-SapuntzakisMDuncanCOxidative DNA damage in prostate cancer patients consuming tomato sauce-based entrees as a whole-food interventionJ Natl Cancer Inst200193241872187911752012
  • AnsariMSGuptaNPA comparison of lycopene and orchidectomy vs orchidectomy alone in the management of advanced prostate cancerBJU Int2003924375378 discussion 37812930422
  • EtminanMTakkoucheBCaamano-IsornaFThe role of tomato products and lycopene in the prevention of prostate cancer: a meta-analysis of observational studiesCancer Epidemiol Biomarkers Prev200413334034515006906
  • SchwarzSObermuller-JevicUCHellmisEKochWJacobiGBiesalskiHKLycopene inhibits disease progression in patients with benign prostate hyperplasiaJ Nutr20081381495318156403
  • KimHSBowenPChenLEffects of tomato sauce consumption on apoptotic cell death in prostate benign hyperplasia and carcinomaNutr Cancer2003471404714769536
  • World Cancer Research Fund/American Institute for Cancer ResearchFood, nutrition, physical activity and the prevention of cancerLondon, UKWCRF International2007
  • PetersULeitzmannMFChatterjeeNSerum lycopene, other carotenoids, and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trialCancer Epidemiol Biomarkers Prev200716596296817507623
  • MohantyNKSaxenaSSinghUPGoyalNKAroraRPLycopene as a chemopreventive agent in the treatment of high-grade prostate intraepithelial neoplasiaUrol Oncol200523638338516301113
  • BalentineDAWisemanSABouwensLCThe chemistry of tea flavonoidsCrit Rev Food Sci Nutr19973786937049447270
  • ChowHHCaiYHakimIAPharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individualsClin Cancer Res2003993312331912960117
  • BettuzziSBrausiMRizziFCastagnettiGPeracchiaGCortiAChemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle studyCancer Res20066621234124016424063
  • BrausiMRizziFBettuzziSChemoprevention of human prostate cancer by green tea catechins: two years later. A follow-up updateEur Urol200854247247318406041
  • McLartyJBigelowRLSmithMElmajianDAnkemMCardelliJATea polyphenols decrease serum levels of prostate-specific antigen, hepatocyte growth factor, and vascular endothelial growth factor in prostate cancer patients and inhibit production of hepatocyte growth factor and vascular endothelial growth factor in vitroCancer Prev Res (Phila)20092767368219542190
  • GaoXLaValleyMPTuckerKLProspective studies of dairy product and calcium intakes and prostate cancer risk: a meta-analysisJ Natl Cancer Inst200597231768177716333032
  • KesseEBertraisSAstorgPDairy products, calcium and phosphorus intake, and the risk of prostate cancer: results of the French prospective SU.VI.MAX (Supplementation en Vitamines et Mineraux Antioxydants) studyBr J Nutr200695353954516512941
  • AllenNEKeyTJApplebyPNAnimal foods, protein, calcium and prostate cancer risk: the European Prospective Investigation into Cancer and NutritionBr J Cancer20089891574158118382426
  • GiovannucciELiuYStampferMJWillettWCA prospective study of calcium intake and incident and fatal prostate cancerCancer Epidemiol Biomarkers Prev200615220321016492906
  • AhnJAlbanesDPetersUDairy products, calcium intake, and risk of prostate cancer in the prostate, lung, colorectal, and ovarian cancer screening trialCancer Epidemiol Biomarkers Prev200716122623263018086766
  • MitrouPNAlbanesDWeinsteinSJA prospective study of dietary calcium, dairy products and prostate cancer risk (Finland)Int J Cancer2007120112466247317278090
  • HsiehTCWuJMResveratrol: biological and pharmaceutical properties as anticancer moleculeBiofactors201036536036920623546
  • HorndaschMCuligZSOCS-3 antagonizes pro-apoptotic effects of TRAIL and resveratrol in prostate cancer cellsProstate292011 [Epub ahead of print]
  • GuptaSCKannappanRReuterSKimJHAggarwalBBChemosensitization of tumors by resveratrolAnn N Y Acad Sci20111215115016021261654